Symbols

LBRX

LB Pharmaceuticals·NASDAQ

--(--)

LBRX Profile

Lb Pharmaceuticals Inc

A clinical stage biopharmaceutical company specializing in the research and development of therapies for neurological and psychiatric disorders

Industry

Pharmaceutical

Established Date

Listing Date

09/11/2025

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.lbpharma.us

Security Type

Common stock

Office address

One Pennsylvania Plaza Suite 1025 New York NY 10119

Business

Introduction

LB Pharmaceuticals Inc was incorporated under the laws of the State of Delaware in September 2015. The company is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and other neuropsychiatric disorders.